Núria Vidal
Impact in
- Neurology top 2%
- Myasthenia Gravis and Thymoma
- Peripheral Neuropathies and Disorders
- Parkinson's Disease and Spinal Disorders
- Autoimmune Neurological Disorders and Treatments
-
- COVID-19 and healthcare impacts
Papers in
-
- Myasthenia Gravis and Thymoma 4
- Peripheral Neuropathies and Disorders 1
-
- Cell Adhesion Molecules Research 1
- Co-authors
- Kushal Lakhani (1 shared paper)Ernesto Guerra-Farfán (1 shared paper)Joan Minguell (1 shared paper)Seper Ekhtiari (1 shared paper)Jorge H. Núñez (1 shared paper)Andrea Sallent (1 shared paper)Álvaro Carbayo Viejo (1 shared paper)Jordi Pegueroles (1 shared paper)
In The Last Decade
Núria Vidal
8 papers receiving 962 citations
Núria Vidal's Hit Papers
Peers
Comparison fields: 5 of 60
- Neurology 640
- Oncology 203
- Infectious Diseases 139
- Emergency Medicine 49
- Immunology 92
Countries citing papers authored by Núria Vidal
This map shows the geographic impact of Núria Vidal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Núria Vidal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Núria Vidal more than expected).
Fields of papers citing papers by Núria Vidal
This network shows the impact of papers produced by Núria Vidal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Núria Vidal. The network helps show where Núria Vidal may publish in the future.
Co-authors
The 12 scholars most cited alongside Núria Vidal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study Hit paper breakdown → | 2017 | 622 |
| 2 | 2020 | 242 | |
| 3 | 2020 | 66 | |
| 4 | 2019 | 46 | |
| 5 | 2019 | 19 | |
| 6 | 2022 | 3 | |
| 7 | 2023 | 2 | |
| 8 | 2025 | 1 |
About Núria Vidal
Núria Vidal is a scholar working on Neurology, Immunology and Allergy, Cell Biology, Pathology and Forensic Medicine and Infectious Diseases, having authored 8 papers that have together received 1.0k indexed citations. Recurring topics across this work include Myasthenia Gravis and Thymoma (4 papers), Multiple Sclerosis Research Studies (1 paper), Cell Adhesion Molecules Research (1 paper), Antifungal resistance and susceptibility (1 paper), COVID-19 and healthcare impacts (1 paper), Caveolin-1 and cellular processes (1 paper), Peripheral Neuropathies and Disorders (1 paper) and Hereditary Neurological Disorders (1 paper). The work is most often cited by research in Neurology (640 citations), Oncology (203 citations), Infectious Diseases (139 citations), Emergency Medicine (49 citations) and Immunology (92 citations). Núria Vidal has collaborated with scholars based in Spain and Canada. Frequent co-authors include Kushal Lakhani, Ernesto Guerra-Farfán, Joan Minguell, Seper Ekhtiari, Jorge H. Núñez, Andrea Sallent, Álvaro Carbayo Viejo, Jordi Pegueroles, Luís Querol and Elba Pascual‐Goñi. Their work appears in journals such as The Lancet Neurology, Quality of Life Research, Journal of Clinical Nursing, Neurology and Journal of the Neurological Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.